Comparison of the median effective concentration (EC50) and effect of sevoflurane with or without remifentanil in cesarean section with supreme laryngeal mask under narcotrend monitoring: a randomized trial.

BACKGROUND Remifentanil combined with sevoflurane is a standard protocol for obstetric general anesthesia (GA). METHODS In this study, we performed a randomized clinical trial to evaluate whether remifentanil has an effect on the median effective concentration (EC50) of sevoflurane and compare anesthetic outcomes of them in cesarean section with Supreme™ laryngeal mask airway (SLMA) under narcotrend monitoring. Ninety parturients with singleton births undergoing elective cesarean delivery (CD) with initial inhaled 1.0 minimum alveolar concentration (MAC) sevoflurane for anesthesia maintenance were assigned to three groups randomly and evenly: Group A (0.05 µg·kg-1·min-1 remifentanil combined with sevoflurane), Group B (0.1 µg·kg-1·min-1 remifentanil combined with sevoflurane), and Group C (normal saline combined with sevoflurane). Narcotrend was used to monitor the depth of anesthesia during the operation, with the level of anesthesia depth controlled within the D-E stage. The EC50 of sevoflurane was determined by Dixon's sequential method. The Narcotrend index, amount of bleeding, neonatal Apgar score, and corresponding treatment measures in the three groups were recorded. RESULTS The results showed that the estimated EC50 of sevoflurane for obstetric GA was 0.80 MAC (95% CI: 0.63-0.95 MAC) in group A, 0.82 MAC (95% CI: 0.63-0.96 MAC) in group B, and 0.80 MAC (95% CI: 0.63-0.95 MAC) in group C. There was no statistically significant difference in the estimated EC50 of sevoflurane, time to wakefulness, Apgar score, amount of intraoperative bleeding, and postoperative bleeding within 24 hours between the three groups (all P>0.05). CONCLUSIONS The addition of remifentanil at 0.05-0.1 µg·kg-1·min-1 did not change the EC50 of sevoflurane and anesthetic quality. The concentration of inhaled anesthetics can be minimized with Narcotrend monitoring. TRIAL REGISTRATION Chinese Clinical Trial Registry ChiCTR2000034512.

[1]  S. Yoon,et al.  Pharmacological strategies to prevent haemodynamic changes after intubation in parturient women with hypertensive disorders of pregnancy: A network meta-analysis , 2021, International journal of medical sciences.

[2]  J. Mhyre,et al.  General Anesthesia for Cesarean Delivery: Occasionally Essential but Best Avoided. , 2019, Anesthesiology.

[3]  M. Harma,et al.  Effects of Preoperative Anxiety and General Anesthetic Administration on Intraoperative Awareness in Patients Undergoing Cesarean Section , 2019, Medical Bulletin of Haseki.

[4]  Guohua Li,et al.  Adverse Events and Factors Associated with Potentially Avoidable Use of General Anesthesia in Cesarean Deliveries , 2019, Anesthesiology.

[5]  Reyhan Arslantaş,et al.  Comparing the effects of general and spinal anesthesia on the postoperative pain intensity in patients undergoing emergent or elective cesarean section , 2019, Marmara Medical Journal.

[6]  F. Xue,et al.  Dexmedetomidine reduces sevoflurane EC50 for supraglottic airway device insertion in spontaneously breathing morbidly obese patients , 2019, Therapeutics and clinical risk management.

[7]  D. Chestnut.  Chestnut's Obstetric Anesthesia: Principles and Practice , 2019 .

[8]  Laleh Dehghanpisheh,et al.  The Effect of Spinal versus General Anesthesia on Quality of Life in Women Undergoing Cesarean Delivery on Maternal Request , 2018, Cureus.

[9]  A. Palanisamy,et al.  Mode of anaesthesia for Caesarean delivery and maternal morbidity: can we overcome confounding by indication? , 2018, British journal of anaesthesia.

[10]  M. El-Tahan,et al.  Comparison of the effects of low doses of dexmedetomidine and remifentanil on the maternal hemodynamic changes during caesarean delivery in patients with severe preeclampsia: a randomized trial. , 2018, Minerva anestesiologica.

[11]  X.X. Sun,et al.  Effects of sevoflurane or propofol combined with remifentanil anesthesia on clinical efficacy and stress response in pregnant women with pregnancy-induced hypertension. , 2018, European review for medical and pharmacological sciences.

[12]  Brenda G. Fahy,et al.  The Technology of Processed Electroencephalogram Monitoring Devices for Assessment of Depth of Anesthesia. , 2018, Anesthesia and analgesia.

[13]  R. Sultana,et al.  Supreme™ laryngeal mask airway use in general Anesthesia for category 2 and 3 Cesarean delivery: a prospective cohort study , 2017, BMC Anesthesiology.

[14]  A. Palanisamy,et al.  Choice of Anesthesia for Cesarean Delivery: An Analysis of the National Anesthesia Clinical Outcomes Registry , 2017, Anesthesia and analgesia.

[15]  L. Trasande,et al.  Geographic Variations and Temporal Trends in Cesarean Delivery Rates in China, 2008-2014 , 2017 .

[16]  M. Van de Velde.  The use of remifentanil during general anesthesia for caesarean section. , 2016, Current opinion in anaesthesiology.

[17]  S. Hagihira,et al.  Rethinking general anesthesia for cesarean section , 2016, Journal of Anesthesia.

[18]  M. Kutlesic,et al.  Attenuation of cardiovascular stress response to endotracheal intubation by the use of remifentanil in patients undergoing Cesarean delivery , 2016, Journal of Anesthesia.

[19]  S. Curtin,et al.  Births: Final Data for 2014. , 2015, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[20]  S. M. Kinsella,et al.  Obstetric Anaesthetists' Association/Difficult Airway Society difficult and failed tracheal intubation guidelines--the way forward for the obstetric airway. , 2015, British journal of anaesthesia.

[21]  Guohua Li,et al.  Temporal Trends in Anesthesia-related Adverse Events in Cesarean Deliveries, New York State, 2003–2012 , 2015, Anesthesiology.

[22]  S. Rex,et al.  General anesthesia for caesarean section , 2015, Current opinion in anaesthesiology.

[23]  S. Segal,et al.  Serious Complications Related to Obstetric Anesthesia: The Serious Complication Repository Project of the Society for Obstetric Anesthesia and Perinatology , 2014, Anesthesiology.

[24]  D. Bansal,et al.  Effect of intranasal dexmedetomidine or oral midazolam premedication on sevoflurane EC50 for successful laryngeal mask airway placement in children: a randomized, double‐blind, placebo‐controlled trial , 2014, Paediatric anaesthesia.

[25]  A. Pournajafian,et al.  Comparison of Remifentanil and Fentanyl Regarding Hemodynamic Changes Due to Endotracheal Intubation in Preeclamptic Parturient Candidate for Cesarean Delivery , 2012, Anesthesiology and pain medicine.

[26]  A. Sia,et al.  The LMA Supreme™ in 700 parturients undergoing Cesarean delivery: an observational study , 2012, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[27]  D. Wong,et al.  Brief review: The LMA Supreme™ supraglottic airway , 2012, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[28]  A. Palanisamy,et al.  General anesthesia for cesarean delivery at a tertiary care hospital from 2000 to 2005: a retrospective analysis and 10-year update. , 2011, International journal of obstetric anesthesia.

[29]  V. Erden,et al.  The effect of labor on sevoflurane requirements during cesarean delivery. , 2011, International journal of obstetric anesthesia.

[30]  E. Brown,et al.  General anesthesia, sleep, and coma. , 2010, The New England journal of medicine.

[31]  A. Nakae,et al.  Pregnancy Does Not Enhance Volatile Anesthetic Sensitivity on the Brain: An Electroencephalographic Analysis Study , 2010, Anesthesiology.

[32]  T. Volk,et al.  A Comparison of Seal in Seven Supraglottic Airway Devices Using a Cadaver Model of Elevated Esophageal Pressure , 2008, Anesthesia and analgesia.

[33]  Jongun Lee,et al.  The Effects of Volatile Anesthetics on Spontaneous Contractility of Isolated Human Pregnant Uterine Muscle: A Comparison Among Sevoflurane, Desflurane, Isoflurane, and Halothane , 2006, Anesthesia and analgesia.

[34]  M. Yalaz,et al.  The Maternal and Neonatal Effects of the Volatile Anaesthetic Agents Desflurane and Sevoflurane in Caesarean Section: A Prospective, Randomized Clinical Study , 2006, The Journal of international medical research.

[35]  K. Chin,et al.  A BIS‐guided study of sevoflurane requirements for adequate depth of anaesthesia in Caesarean section , 2004, Anaesthesia.

[36]  C. Grebenik,et al.  General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases. , 2004, International journal of obstetric anesthesia.

[37]  K. Chin,et al.  Bispectral Index Values at Sevoflurane Concentrations of 1% and 1.5% in Lower Segment Cesarean Delivery , 2004, Anesthesia and analgesia.

[38]  Thomas Standl,et al.  Narcotrend® and Bispectral Index® Monitor Are Superior to Classic Electroencephalographic Parameters for the Assessment of Anesthetic States during Propofol-Remifentanil Anesthesia , 2003, Anesthesiology.

[39]  S. Gatt,et al.  The in-vitro effects of sevoflurane and desflurane on the contractility of pregnant human uterine muscle. , 2002, International journal of obstetric anesthesia.

[40]  J. Brimacombe,et al.  The laryngeal mask airway is effectièe (and probably safe) in selected healthy parturients for electièe Cesarean section: a prospectièe study of 1067 cases , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[41]  C. McCarroll,et al.  Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section. , 2001, British journal of anaesthesia.

[42]  T D Egan,et al.  Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000. , 2000, Current opinion in anaesthesiology.

[43]  D. N. Gow,et al.  The caesarean section , 1996, The Medical journal of Australia.